4,142 Shares in CME Group Inc. $CME Bought by Leonteq Securities AG

Leonteq Securities AG acquired a new position in shares of CME Group Inc. (NASDAQ:CME) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 4,142 shares of the financial services provider’s stock, valued at approximately $1,131,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Asset Dedication LLC raised its holdings in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the period. FNY Investment Advisers LLC acquired a new stake in shares of CME Group during the fourth quarter worth $27,000. Legacy Wealth Managment LLC ID raised its holdings in shares of CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 71 shares during the period. Global Wealth Strategies & Associates raised its holdings in shares of CME Group by 1,250.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 100 shares during the period. Finally, Anfield Capital Management LLC raised its holdings in shares of CME Group by 197.4% during the fourth quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 75 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other CME Group news, General Counsel Jonathan L. Marcus sold 3,291 shares of the firm’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the sale, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. This trade represents a 31.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total value of $1,300,530.00. Following the sale, the director directly owned 43,007 shares of the company’s stock, valued at $13,317,117.55. This represents a 8.90% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 48,244 shares of company stock worth $14,598,037. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. TD Cowen decreased their price target on shares of CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft decreased their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Piper Sandler raised their price target on shares of CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 15th. Finally, Erste Group Bank raised shares of CME Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, March 5th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, CME Group has an average rating of “Moderate Buy” and a consensus target price of $305.29.

CME Group Price Performance

NASDAQ:CME opened at $289.29 on Friday. CME Group Inc. has a 1-year low of $257.17 and a 1-year high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a fifty day simple moving average of $296.62 and a 200 day simple moving average of $289.10. The stock has a market capitalization of $104.83 billion, a PE ratio of 24.68, a P/E/G ratio of 3.51 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same period last year, the business earned $2.80 earnings per share. The firm’s revenue was up 14.5% on a year-over-year basis. On average, research analysts expect that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.